Clinical Trial Update: Effect of Sevelamer on P-cresol Levels in CKD [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating whether sevelamer lowers p-cresol levels in adults with chronic kidney disease stages 3-5.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Sevelamer (sevelamer hydrochloride)

Snippet

Sponsor: Federico II University | Conditions: Chronic Kidney Disease Stage 3-5 | Phase 3 | Status: UNKNOWN